Mononucleosis News and Research

RSS
Specialized natural killer cells in human tonsils help protect against Epstein Barr virus

Specialized natural killer cells in human tonsils help protect against Epstein Barr virus

Vaccine shows promise in preventing glandular fever

Vaccine shows promise in preventing glandular fever

Pathogen Simulation provides a new approach to the study of Epstein-Barr virus

Pathogen Simulation provides a new approach to the study of Epstein-Barr virus

Do not ignore fatigue

Do not ignore fatigue

ViroPharma receives orphan drug designation for Maribavir

ViroPharma receives orphan drug designation for Maribavir

Chronic fatigue syndrome a public health epidemic says CDC

Chronic fatigue syndrome a public health epidemic says CDC

Innovative approach for creating a cytomegalovirus vaccine

Innovative approach for creating a cytomegalovirus vaccine

Epstein-Barr virus may trigger multiple sclerosis

Epstein-Barr virus may trigger multiple sclerosis

Genetic clue found to Chronic Fatigue Syndrome

Genetic clue found to Chronic Fatigue Syndrome

Epstein-Barr virus infection linked to multiple sclerosis

Epstein-Barr virus infection linked to multiple sclerosis

Taking aim at one of mankind's most common diseases

Taking aim at one of mankind's most common diseases

FDA grants fast track status for ViroPharma's Maribavir

FDA grants fast track status for ViroPharma's Maribavir

Corticosteroids often used in the treatment of infectious mononucleosis

Corticosteroids often used in the treatment of infectious mononucleosis

Experimental drug for diabetes looks promising

Experimental drug for diabetes looks promising

Research provides roadmap for the development of human therapies for cytomegalovirus (CMV)

Research provides roadmap for the development of human therapies for cytomegalovirus (CMV)

Epstein-Barr virus may increase risk of lupus

Epstein-Barr virus may increase risk of lupus

Link between a critical cancer pathway and an Epstein-Barr Virus (EBV) protein

Link between a critical cancer pathway and an Epstein-Barr Virus (EBV) protein

Antigens produced by the Epstein Barr virus may provide an ideal target for cancer therapy

Antigens produced by the Epstein Barr virus may provide an ideal target for cancer therapy

Exposure to infant siblings decreases multiple sclerosis risk

Exposure to infant siblings decreases multiple sclerosis risk

Day care or nursery school attendance may reduce risk of developing Hodgkin's disease

Day care or nursery school attendance may reduce risk of developing Hodgkin's disease